To Study the effect of Samvardhana Ghrita and Panchakarmain the Management of Cerebral Palsy

Clinical Study on Samvardhana Ghrita and Panchakarma in the Management of Cerebral Palsy in Children: ARandomized Controlled Trial - no

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034028

Enrollment

Registered

2021-06-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G809- Cerebral palsy, unspecified

Interventions

Intervention1: Group A: ORAL DRUG SAMVARDHANA GHRITA ,1ml/Kg/Day FOR 3 MONTH PHYSIOTHERAPY -25-30 min/day FOR 3 MONTH abhyanga -saptanga masa tail-25-30 min/day FOR 3 MONTH shastikashali pinda sweda -

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group of 2 to 12 years of either sex. 2. Diagnosed Case of spastic cerebral palsy without seizures.

Exclusion criteria

Exclusion criteria: 1. Progressive neurological disorder. 2.Presence of seizures

Design outcomes

Primary

Measure	Time frame
Change in Gross Motor Function Classification Scale (GMFCS).Timepoint: 90 days	—

Secondary

Measure	Time frame
1. Early rehabilitation and to prevent further complication. 2. Change in i. CDC grading scale for motor milestones ii. Modified Ashworth Scale for spasticity iii. MRC Scale of Power grading for muscle strength iv. Modified Barthel Score of ADLTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDR NISHA KUMARI OJHA

NATIONAL INSTITUTE OF AYURVEDA

drnishaojha@gmail.com9468650449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026